ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
about
Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.Radiological surveillance in multiple endocrine neoplasia type 1: a double-edged sword?Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target.Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms.A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomasA Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease managementPancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.Endoscopy-guided ablation of pancreatic lesions: Technical possibilities and clinical outlook.Disseminated Pancreatic Neuroendocrine Neoplasm (NEN) with an Uncommon Localisation in the Central Nervous System. A Case ReportNon-surgical ablative therapies for inoperable benign insulinoma.Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis.Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours.Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements.Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.The treatment of hyperinsulinemic hypoglycaemia in adults: an update.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patients.Parenchyma-sparing surgery for pancreatic endocrine tumors.Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence.Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.Watch and wait policy in advanced neuroendocrine tumors: What does it mean?Algorithm guided outlining of 105 pancreatic cancer liver metastases in Ultrasound.Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors.Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases.Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).Should the Selective Arterial Secretagogue Injection Test for Insulinoma Localization Be Evaluated at 60 or 120 Seconds?Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours.Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms.The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors.The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.CT follow-up in patients with neuroendocrine tumors (NETs): combined radiation and contrast dose reduction.Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference.Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 /PET.
P2860
Q28078610-EFC850B8-B6C7-4BDE-88B9-65825E07C4C4Q30491060-8E7CF7F3-9E85-4206-AF9F-D9535E9CC30AQ33573118-4041F297-EFED-4A34-8017-5F4F3F04EBA1Q33606047-5D35D8EA-91D2-4A4F-9002-91F139370B58Q33651984-6E7C9386-13AD-48C6-80D5-F5762AC3F853Q33656493-8425170C-CC51-4E7F-A2D0-685BCE24B426Q33672117-14AD21A5-AF0C-4393-B402-0DE01BADFE25Q36154116-9CFB03C9-80CC-4C6B-ABE0-3008BB22E74BQ36300041-2FA84B1D-D6B9-4893-B0EE-4CF120C8FDD9Q37302087-5D87AA8E-DD57-44F9-A6E0-57A23A97ED47Q37586258-994022EC-A357-475E-A01F-311F039E7E02Q37644113-C8082A84-A164-45D4-8C69-79DDFBDCAF69Q37691470-35EFB741-C223-409C-B06F-EE492F18868BQ38654200-03ED5E3D-4D08-4548-878C-DB48C555709CQ38691825-1CB5006D-E77A-44DE-A81C-8941E4944C57Q38808729-7EC0BF5E-3384-43A6-A1FE-DF04BB8082E7Q38910448-2DFB10EF-B0E0-40F9-A973-98B3443CF42CQ38931272-863B9B0E-7ECD-4214-87E9-94C52BE860A9Q38953515-1E0EC05E-27E2-41DE-A570-6B4338D2CE7BQ38956091-4242E27F-C6DB-4367-8479-9B8186CCE2E9Q39016753-8172FD9F-14AE-4507-8EFF-147D4989B5BBQ39140540-084968BB-D5ED-4BD6-8743-13E169D98F24Q39317685-35C1F72B-D16C-4536-9AA9-2C5FC2057B92Q39547207-28CC7500-1FBF-4055-A446-3F6F8A1D3E16Q40587447-A9918F1A-79FC-4F3C-88F4-4FCD29B55A41Q42365077-BF698983-3770-402F-AAEC-204009B5B112Q42371783-E58C8BE2-BAA3-4375-B232-ED272B554458Q45890813-FF0BFF53-8D43-49E1-9F1F-E45AC67FF72BQ47137707-F8C54D31-0F74-432F-B824-883710A9C797Q47142152-ED441CC2-5096-4FF0-A6CF-6B76C6D4845BQ47144145-E732C431-6EB5-4EDD-BD7C-F554AC48E21EQ47150030-EBC6E333-9722-4B36-AD95-19F8813BD3E4Q47179409-A3212961-4C9A-40D9-B698-959B9510E0F6Q47615122-0B3BC292-6A07-482D-B9D3-938120028F68Q47731752-23A652A3-B837-4A96-B7CA-82A001826290Q47822235-7DA07D87-9DC3-4543-BFCC-3DFB2D9601B7Q48143840-2DCDC042-6DF6-4614-8D30-DD213CF2F34FQ48275143-7946EE54-9DBA-4772-8DAE-581F1CD32CD2Q48695691-C43B8EB9-929D-4ADD-A576-AD095A2F817FQ49165538-78B1CD4B-A64B-4F03-9037-305F7AB695A3
P2860
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
ENETS Consensus Guidelines Upd ...... creatic Neuroendocrine Tumors.
@en
type
label
ENETS Consensus Guidelines Upd ...... creatic Neuroendocrine Tumors.
@en
prefLabel
ENETS Consensus Guidelines Upd ...... creatic Neuroendocrine Tumors.
@en
P2093
P2860
P50
P356
P1433
P1476
ENETS Consensus Guidelines Upd ...... ncreatic Neuroendocrine Tumors
@en
P2093
B Eriksson
D K Bartsch
D Kwekkeboom
J Capdevila
R Kianmanesh
R T Jensen
P2860
P304
P356
10.1159/000443171
P577
2016-01-05T00:00:00Z